Skip to content

esketamine

Articles tagged with “esketamine

11 articles
Side Effects & Dropout Rates: New Data on Ketamine for TRD — ketamine side effects discontinuation rates study 2026

Side Effects & Dropout Rates: New Data on Ketamine for TRD

New clinical guidance on NMDA antagonist side effects and dropout rates offers practical insight for patients considering ketamine therapy for TRD.

Read
news

Why Patients Quit NMDA Therapy—And What Providers Should Do

New clinical review urges faster dose optimization and earlier switching between NMDA therapies for treatment-resistant depression. Here's what it means for patients.

news

When to Push for Stronger TRD Treatments, Per Experts

Psychiatric Times highlights underuse of highly effective TRD treatments. Here's what this means if you or a loved one is stuck in a cycle of failed antidepressants.

news

NMDA Side Effects: What Dropout Rates Mean for Patients

New clinical guidance on NMDA antagonist side effects and dropout rates offers practical insights for patients considering ketamine or esketamine therapy.

news

Ketamine Side Effects: What New Clinical Data Reveals

New clinical analysis examines side effect profiles and discontinuation rates for ketamine and esketamine. Here's what treatment-resistant depression patients should know.

news

Ketamine Side Effects: What New Data Tells Patients

A new clinical review examines side effect profiles and discontinuation rates for NMDA antagonists like ketamine and esketamine. Here's what patients should know.

news

Ketamine Side Effects: What New Data Means for Patients

New clinical guidance on NMDA antagonist side effects and discontinuation rates gives patients and families sharper questions to ask before starting ketamine therapy.

news

How Doctors Choose Ketamine vs. Other TRD Treatments

New clinical guidance explains how psychiatrists choose between esketamine, ketamine, and brain stimulation for treatment-resistant depression patients.

news

Esketamine's Role in Treatment-Resistant Depression Care

New clinical guidance on esketamine for treatment-resistant depression highlights patient preferences, access barriers, and rapid-acting options for suicidal depression.

compare

Generic Ketamine vs Spravato: Comparing Off-Label and FDA-Approved Options

A comprehensive comparison of generic (racemic) ketamine and Spravato (esketamine nasal spray) — covering FDA approval, effectiveness, cost, insurance coverage, and how to choose between them.

journeys

What a Spravato (Esketamine) Nasal Spray Session Is Really Like

What a Spravato nasal spray session feels like from start to finish — the check-in, administration, monitoring period, and what to expect during your visit.

Need help or want to reach readers?

Have a correction, provider question, or advertising inquiry? Reach the editorial team.